New asthma and COPD treatment, benralizumab, cuts need for further treatment by 30% compared to steroids.

Scientists have discovered a new treatment for asthma and COPD, called benralizumab, which reduces the need for further treatment by 30% compared to steroid tablets. Administered as an injection, benralizumab targets specific white blood cells to reduce lung inflammation. The treatment could potentially be given at home or in a doctor's office, reducing hospital visits and the risk of steroid side effects like diabetes and osteoporosis. This breakthrough marks the first new asthma treatment in 50 years.

4 months ago
62 Articles

Further Reading